Karl Fredrik Sjövall
Presidente presso ZICCUM AB
Posizioni attive di Karl Fredrik Sjövall
Società | Posizione | Inizio | Fine |
---|---|---|---|
ZICCUM AB | Independent Dir/Board Member | 05/04/2017 | - |
Presidente | 05/04/2017 | - | |
Amministratore Delegato | - | 09/05/2022 | |
LIPIDOR AB | Presidente | 01/01/2020 | - |
Direttore/Membro del Consiglio | 01/01/2018 | 01/01/2020 | |
MONIVENT AB | Presidente | 01/05/2019 | - |
Independent Dir/Board Member | 01/05/2019 | - | |
Axelero AB | Direttore/Membro del Consiglio | 01/10/2009 | - |
Emollivet AB | Presidente | - | - |
Phargentis AB | Direttore/Membro del Consiglio | - | - |
Storia della carriera di Karl Fredrik Sjövall
Precedenti posizioni note di Karl Fredrik Sjövall
Società | Posizione | Inizio | Fine |
---|---|---|---|
ECTIN RESEARCH AB | Presidente | 01/01/2020 | - |
BIO VITOS PHARMA AB | Direttore/Membro del Consiglio | - | - |
Amministratore Delegato | - | - | |
Presidente | 01/10/2015 | - | |
INHALATION SCIENCES SWEDEN AB | Amministratore Delegato | 01/05/2018 | - |
Presidente | 01/05/2018 | - | |
░░░░░░░ ░░░░░░ ░░ | ░░░░░ ░░░░░░░░░ ░░░░░░░ | - | - |
░░░░░░░░░ ░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ | - |
░░░░░░░░░░░░░ ░░ ░░░░░░ ░░ | ░░░░░ ░░░░░░░░░ ░░░░░░░ | - | - |
Formazione di Karl Fredrik Sjövall
Chalmers University of Technology | Graduate Degree |
Statistiche
Distribuzione geografica
Svezia | 13 |
Norvegia | 2 |
Posizioni
Chairman | 7 |
Chief Executive Officer | 5 |
Director/Board Member | 4 |
Settori
Health Technology | 9 |
Consumer Services | 2 |
Commercial Services | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
Società quotate in Borsa | 6 |
---|---|
LIPIDOR AB | Commercial Services |
INHALATION SCIENCES SWEDEN AB | Health Technology |
BIO VITOS PHARMA AB | Health Technology |
MONIVENT AB | Health Technology |
ZICCUM AB | Health Technology |
ECTIN RESEARCH AB | Health Technology |
Aziende private | 6 |
---|---|
Biosergen AS
Biosergen AS BiotechnologyHealth Technology Biosergen AS develops drugs based on biosynthetic engineering of natural products, combined with chemical synthesis. It develops antibiotics for the use in antifungal therapy. The firm uses engineered biosynthesis technology that allows alterations in microbial genes, which lead to predictable changes in the final structure of the natural product. The company was founded in 2004 and is headquartered in Tiller, Norway. | Health Technology |
Promore Pharma AB
Promore Pharma AB BiotechnologyHealth Technology Promore Pharma AB is a biopharmaceutical company, which engages in the development of therapeutic peptides for the bioactive wound care market. The company was founded by Mona Ståhle and Johan Heilborn on January 29, 2003 and is headquartered in Solna, Sweden. | Health Technology |
PharmaSurgics In Sweden AB
PharmaSurgics In Sweden AB Pharmaceuticals: MajorHealth Technology PharmaSurgics is a clinical stage biotech company developing novel treatments for the prevention of harmful scarring (adhesions) after surgery. Post-surgical adhesions develop in millions of patients every year and are a source of great patient suffering and enormous healthcare expenditures. The company was founded in 2005 after extensive research done by Dr Inger Mattsby-Baltzer, PhD and Professor Kjell Olmarker MD, PhD at the Sahlgrenska Academy. PharmaSurgics is based in Göteborg, Sweden, where comprehensive in vitro and in vivo facilities have been established. | Health Technology |
Axelero AB | |
Emollivet AB | |
Phargentis AB |
- Borsa valori
- Insiders
- Karl Fredrik Sjövall
- Esperienza